Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Apr. 30, 2025	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities
Net (loss) income	$ (108,114)	$ 61,720	$ (236,161)
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation and amortization	12,315	17,999	20,233
Amortization of premium and accretion of discount on marketable securities, net	(7,186)	(8,808)	(772)
Amortization of deferred contract acquisition costs	96,688	78,549	68,900
Amortization of debt issuance costs	1,117	1,069	1,023
Non-cash operating lease cost	10,040	11,010	10,880
Asset impairment charges	0	0	6,242
Stock-based compensation expense	257,782	239,137	204,039
Deferred income taxes	57,431	(217,195)	(2,007)
Unrealized foreign currency transaction loss (gain)	2,211	1,930	(1,386)
Other	39	(34)	44
Changes in operating assets and liabilities, net of impact of business acquisitions:
Accounts receivable, net	(48,903)	(63,519)	(46,353)
Deferred contract acquisition costs	(106,691)	(119,834)	(102,017)
Prepaid expenses and other current assets	(25,320)	(2,875)	1,323
Other assets	(10,794)	1,906	8,525
Accounts payable	(8,952)	(9,998)	6,304
Accrued expenses and other liabilities	9,845	18,144	4,310
Accrued compensation and benefits	(546)	17,357	8,324
Operating lease liabilities	(11,906)	(12,391)	(11,405)
Deferred revenue	147,112	134,595	95,616
Net cash provided by operating activities	266,168	148,762	35,662
Cash flows from investing activities
Purchases of property and equipment	(4,345)	(3,450)	(2,684)
Business acquisitions, net of cash acquired	0	(19,100)	0
Purchases of marketable securities	(549,574)	(536,833)	(270,268)
Sales, maturities, and redemptions of marketable securities	435,251	271,423	0
Net cash used in investing activities	(118,668)	(287,960)	(272,952)
Cash flows from financing activities
Proceeds from issuance of ordinary shares under employee stock purchase plan	23,093	19,135	0
Proceeds from issuance of ordinary shares upon exercise of stock options	17,854	20,919	17,471
Net cash provided by financing activities	40,947	40,054	17,471
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(322)	(4,407)	2,822
Net increase (decrease) in cash, cash equivalents, and restricted cash	188,125	(103,551)	(216,997)
Cash, cash equivalents, and restricted cash, beginning of period	543,089	646,640	863,637
Cash, cash equivalents, and restricted cash, end of period	731,214	543,089	646,640
Supplemental disclosures of cash flow information
Cash paid for interest	24,191	25,063	24,136
Cash paid for income taxes, net	21,994	24,219	11,581
Cash paid for operating lease liabilities	13,127	14,000	13,136
Supplemental disclosures of non-cash investing and financing information
Property and equipment included in accounts payable	305	398	121
Operating lease right-of-use assets for new lease obligations	11,771	11,539	10,902
Acquisition-related indemnity holdback	$ 0	$ 3,000	$ 0